Plasma and urine beta-thromboglobulin in severe preeclampsia

J. R. Leiberman, Z. J. Hagay, M. Mazor, M. Aharon, I. Nathan, A. Dvilansky

Research output: Contribution to journalArticlepeer-review

6 Scopus citations


Beta-thromboglobulin (BTG) has been shown to be a specific platelet protein and can be used as a marker of platelet activation in preeclampsia. Concomitant studies of BTG levels in plasma and urine were performed with eight primiparous severe preeclamptic patients and eight normal primiparous women matched for age. The mean plasma BTG in the severe preeclamptic patients was 186.62±29.93 ng/ml, and in the control group 45.38±31.84 ng/ml. The P-value for the difference was highly significant (P=0.000). In contrast, the mean urine BTG in the study group was 8.42±4.61 ng/ml, while the mean value for the control group was similar, 5.00±3.20 ng/ml. The P-value for the difference was not significant (0.05<P<0.10). These results show that urinary BTG cannot be considered an indicator of platelet activation in severe preeclampsia. A low rather express renal impairment. Failure of BTG renal clearance would contribute to further raising the level of plasma BTG.

Original languageEnglish
Pages (from-to)165-168
Number of pages4
JournalArchives of Gynecology and Obstetrics
Issue number3
StatePublished - 1 Sep 1988
Externally publishedYes


  • Beta-thromboglobulin
  • Hematological tests
  • Preeclampsia
  • Renal failure
  • Urinary beta-thromboglobulin

ASJC Scopus subject areas

  • Obstetrics and Gynecology


Dive into the research topics of 'Plasma and urine beta-thromboglobulin in severe preeclampsia'. Together they form a unique fingerprint.

Cite this